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ABSTRACT 
In November 2016, the International Pharmaceutical Federation (FIP) endeavored to create an environment to foster a shared vision to 
lead a transformative pharmaceutical workforce roadmap. Three milestone documents were developed and presented at the Global 
Conference on Pharmacy and Pharmaceutical Education. Workshops with the key themes and connecting Pharmaceutical Workforce 
Development Goals (PWDG) were conducted and analyzed. This Note serves to summarize the key aspects of these workshops, reporting 
on the innovative approaches used to generate guidance for stakeholders regarding implementation. 
Innovation: Seven workshops with a uniform structure were developed. These were designed to improve communication, harmonise 
outcome-generation, and allow for aggregate analysis. A team of seven conducted each workshop, each team consisted of: a Chair, a 
facilitator, one rapporteur, and four speakers purposively selected from FIP member organisations and other key stakeholders with 
expertise for sharing a variety of perspectives. Guidelines and templates were developed for all roles and each team was briefed in 
advance.   
Key findings: Approximately 200 personnel participated in the seven workshops, with around 20 country representatives per workshop, 
covering all six World Health Organisation regions. Three key aspects of workforce transformation, using the PWDGs, were explored in 
each workshop: drivers for implementation; challenges to implementation; and ways of encouraging implementation. Drivers for 
implementation mentioned were enhancing collaboration and engagement. Challenges to implementation were identified as variance in 
terminology. Several ways of encouraging implementation were acknowledged, such as communication strategies, advocating for 
workforce development and sharing best practices to foster partnerships.  
Next steps: The unique format of the workshops, the innovative approach to include stakeholders across an array of settings and the 
parallel structure in all the seven workshops, aided in creating reliable findings.  The achievability of the PWDGs depends on several 
factors. Engagement with stakeholders and engagement from and between professional associations are important factors to achieving 
workforce development goals. 
 
Key Words: pharmacy education, pharmaceutical education, transformative education, roadmap, pharmaceutical workforce 
development goals. 
 
 
Description 
Creating the pharmaceutical workforce required to adequately 
address the world’s medicines-related needs is an important and 
complex process. Achieving this requires creating a shared vision, 
setting agreed objectives, using culturally appropriate strategies 
for local action, and designing mechanisms for global 
aggregation of outcomes. These processes cannot be initiated 
without a critical mass of key decision-makers working together  
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in an environment of mutual trust to generate guidance. In 
November 2016, the International Pharmaceutical Federation 
(FIP) endeavored to create such an environment and use it to 
premier a transformative pharmaceutical workforce roadmap.  
 
In 2016, a workforce roadmap, including three milestone 
documents1-3 (Global vision for Education and Workforce, 
Pharmaceutical Workforce Development Goals (PWDGs), 
Statements on Pharmacy and Pharmaceutical Sciences 
Education), was developed through a multi-stage consultation 
with educators, practitioners, policy-makers, and scientists 
worldwide. The concepts and all the documents were broadly 
discussed in pharmacy and pharmaceutical sciences 
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communities before being endorsed by 153 delegates 
representing professional bodies and regulatory authorities from 
46 countries at the Global Conference on Pharmacy and 
Pharmaceutical Sciences Education held in Nanjing, China. The 
creation and endorsement of the workforce roadmap is 
described in detail in the report entitled, “Transforming 
pharmacy and pharmaceutical sciences education in the context 
of workforce development”4. 
 
The PWDGs2 can act as a mechanism to prepare a 
pharmaceutical workforce that is able to better meet 
pharmaceutical healthcare needs and the development of 
medicines expertise and science. An adapted framework method 
analysis5 was used to develop the final 13 PWDGs. Extensive 
external and internal consultation processes included: a review 
of health workforce literature6,7 and FIP Education outputs since 
20088; internal FIP consultation with leadership of Member 
Organisations, Executive Committee, Bureau, Boards and FIP 
Education; and a public and organisational consultation.  Along 
with the relevant literature, the PWDGs formed the basis of 
workshops undertaken at the Global Conference. There are 13 
PWDGs, gathered into three clusters: 1) Academy focuses goals 
for schools, universities and education providers; 2) Professional 
Development focuses on goals for the pharmaceutical 
workforce; 3) Systems focuses on goals for policy development, 
governmental strategy and planning, and monitoring systems. 
For each, a summative set of drivers, imperatives and indicators 
is provided to guide pharmaceutical stakeholders in their use to 
assess the current status of their own workforce development 
and assist in the development of strategies at a national level.   
 
At the Global Conference and following scene-setting plenary 
sessions, official conference delegates and other participants 
representing various aspects of pharmacy and pharmaceutical 
sciences engaged in novel workshops designed to:  a) highlight 
local work related to the transformation of the pharmaceutical 
workforce, b) generate ideas for local and global actions in 
support of the pharmaceutical workforce development goals 
(PWDGs), and c) propose methods for communication about the 
PWDGs and progress toward achieving them. Overall, seven 
multinational workshops were held (see Table 1) centred on key 
themes gathered previously from the health workforce literature 
and extended to include the relevant PWDGs. The participants 
were asked to choose two workshops to attend, resulting in a 
convenience sampling approach. Participants discussed issues on 
their roundtables first, then shared their results with the overall 
group. This Note serves to summarize key aspects of these 
workshops (that served as basis to understand the feasibility of 
how the PWDGs could be implemented in different countries), 
report on the innovative approaches used and major outcomes 
realized, in order to generate guidance for stakeholders 
regarding PWDGs implementation.  
 
 
 
 
Innovation 
Workshop selection 
Around 600 registrants attended the Global Conference from 46 
countries (including 400 Chinese registrants from the hosting 
country, who participated in a parallel national Chinese 
programme).  An estimated 200 delegates participated in the 
seven workshops, with a representation of approximately 20 
countries per workshop covering all six World Health 
Organisation regions (data retrieved from the registration for the 
conference and workshop attendance lists).  
 
All conference participants were asked to select two workshops 
in which to participate. Table 1 provides an overview of the 
workshop topics and questions discussed.  Although participants 
could make this choice based upon their interest, the size of the 
sessions served to promote diversity of geography, interest, and 
experience. Workshops included participants from 40 to 60 
countries in total, with smaller roundtable groups of between 6 
to 8. Workshop facilitation staff further promoted this diversity 
by monitoring seating arrangements. 
 
Workshop structure 
A team of seven conducted each workshop. Each team consisted 
of a Chair from the Conference Steering Committee, a facilitator 
from the FIP Education Development Team, one rapporteur from 
the FIP Education Development Team, and four speakers 
purposively selected from FIP member organisations and other 
key stakeholders with expertise for sharing a variety of 
perspectives. Guidelines and templates were developed for all 
roles and each team was briefed in advance about their 
responsibilities.   
 
A uniform structure was used for all seven multinational 
workshops. The structure was designed to improve 
communication, harmonise outcome-generation, and allow for 
aggregate analysis. At the start of each workshop, the chair 
provided an overview of the topic and the relevant PWDGs to 
contextualise the "how/when/what" of workforce development. 
The four speakers presented sequentially the “where and why” 
perspectives, focusing on a principal challenge for their country 
or organisation, their priority for action, and further insights. 
Following this, the facilitator introduced an activity designed to 
stimulate “what’s next” dialogue on the topics and case 
presentations. Rapporteurs created summative reports of these 
proceedings using proforma templates (see Figure 1).  
 
Workshop outcomes 
At the end of each workshop, the Chair, facilitator and 
rapporteur collaborated to produce summary slides which were 
collated and presented at the closing session of the Conference. 
Presentations of the workshop planning outputs focused on 
continuing stakeholder engagement, communication of the 
conference outcomes, action-planning, and monitoring and 
evaluation of PWDG progress.  
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Following the conclusion of the Conference, the Chairs and/or 
facilitators completed a one-page outcomes template: setting 
the scene, summarising the workshop, and describing main calls 
for action. The rapporteur reports, summary slides, and 
outcomes template were triangulated to provide a 
comprehensive basis for the analysis of the workshop outcomes. 
The data was organised by AB and LB using NVivo® software (QSR 
International; Melbourne, Australia) to detect common themes 
and patterns. Content analysis was conducted to ensure the 
common themes were aggregated in response to the three main 
questions used in all seven workshops. Drivers for 
implementation, challenges to implementation and 
dissemination strategies were described. The emerging themes 
within those topics were categorised and are illustrated in the 
key findings. 
 
Key Findings 
Drivers for implementation 
Enhanced interprofessional, multi-professional and multi-
stakeholder collaboration was described as an important driver 
for change (Workshop (WS) 3). Identifying ways to promote 
better collaboration with stakeholders, overcome organisational 
and bureaucratic barriers, and building collaborative channels 
were all discussed by the participants. Promoting 
interprofessional education (PWDG8) was seen as contributing 
to enhancing academic capacity (PWDG1) (WS 1).  
 
It was considered that regulatory bodies and the academy will 
need to collaborate to ensure the profession is aligned with 
current and changing societal, patient and community needs. 
Engagement between the academy, government agencies and 
practicing professionals is critical to ensure that curricular 
changes align with advances in practice and focus on patient 
outcomes (PWDG 6 and 9) (WS 5). 
 
The impact of automation and technology on practice, science 
and education was identified as a potential driver for 
implementation. It was reported (WS 2, WS 7) that automation 
can help influence achievability of academic capacity by 
improving education (e.g. simulation, e-learning).  
 
Foundation training (early career experiential training) was 
considered crucial to underpin advancement and there was an 
identified need for policy and education structural changes via a 
top-down approach. There is also a need for a shared 
understanding of what advanced and specialist expert 
development is and for stakeholder recognition about its value 
(PWDG 2 and 4) (WS 6).  
 
The need for post-registration (or post-licensure) education and 
training systems to be modified to assure the clinical 
competence of pharmacists (PWDG 5 and 11) was highlighted. In 
order to provide patient-focused services within a country, 
pharmacists must be both adequate in number and competent 
in a variety of individual and team-based skills. Therefore, in 
practice, support systems are needed to allow pharmacists to 
provide clinical services (WS 7). 
 
Challenges to implementation 
The continued lack of collaboration between educational 
providers and pharmacy stakeholders was reported to be a 
challenge (PWDG 3); investing in establishing multi-stakeholder 
networks can help overcome this challenge. Similarly, limited 
interprofessional collaboration can be a barrier to understanding 
roles and responsibilities and hence pose as a barrier for 
implementing PWDG 8 (WS 2, 3).  
 
Variance in terminology and definitions was a recurring theme 
across all workshops (WS 1, 3, 4, 5, 6) and was identified as being 
both a driver (if a common terminology could be agreed) and a 
barrier to implementation (when different meanings can be 
found globally for the same concept). Defining the workforce 
development Goals and understanding their meaning and scope 
are seen as crucial elements to measuring and monitoring 
progress. The ability to reach consensus on terminology and how 
terms are defined is seen as a major challenge to global action 
planning.   
 
WS 4 participants discussed at length their different 
understandings of PWDG 7 – Service provision and workforce 
education and training description (for example ‘foundation 
training’ was thought by some to be linked to initial education 
rather than workforce education and training, and by others to 
be – more aptly – early career training) and stressed the need to 
clarify the goals given the wide range of the particular workforce 
needs in each country (PWDG 13). Lack of consensus on 
terminology was identified as a barrier to achievability as some 
terminology has different contextual meanings in different 
countries and monitoring progress can therefore become more 
difficult; a ‘terminology and definitions framework’ was 
suggested as a means to understanding different perceptions 
(WS 6).  
 
Limitations in resources and technical capacity can hinder the 
integration of technology and education (WS 1). Financial 
resources in the form of financial incentives and re-imbursement 
models may be required to support the development of some 
goals such as PWDG 8 and PWDG 6. Participants also noted that 
incentives to achieve collaborative practice may be needed to 
secure government support to create the expectation practice 
and payment models needed to truly support delivery of patient-
centred care from a collaborative health care team (WS 3). 
Financial resources are particularly important for driving 
advanced practice and specialisation (PWDG 4) as remuneration 
and financial incentives drive the provision of advanced services; 
professional recognition (financial or otherwise) can also 
demonstrate tangible benefits for practitioners, thereby 
encouraging pharmacy advancement and/or specialisation (WS 
6).  
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Ways of disseminating implementation strategy 
Top down and bottom up public and organisational 
communication strategies are key to promoting and 
disseminating the PWDGs; one example of a top down approach 
is engaging with health ministries to support the dissemination 
of the message to local councils and boards (WS 6). Professional 
leadership associations should also develop communication 
strategies to disseminate the goals, and support should be 
provided to develop communication strategies that can support 
liaison with local regulatory bodies or governments (WS 5). 
Having a “point person” in each country to communicate 
national goals to ensure consistent communication was also 
suggested (WS 2).  
 
Research output and scientific publications are also highlighted 
as an important dissemination strategy. This includes public 
communication strategies and developing guidelines for sharing 
and creating global centres of excellence (WS 4).  
 
Pharmacy leaders’ ability to advocate for the workforce and 
demonstrate to educational, healthcare, and financial 
policymakers the value of investing in the pharmaceutical 
workforce is important. This investment is critical for the future 
of safe and effective medicines development, access and use (WS 
7). Alternatively, investing in leadership development 
programmes targeted at key lead pharmacists in government 
positions could in turn steer the profession nationally and 
internationally (WS 5).  
 
Identifying and sharing existing best practices were reported to 
support goal achievability through needs-based adaptability, 
learning from real-life cases and examples, and widen 
contribution and engagement (WS 7). Identifying best practice 
was seen as a particularly important driver to achieving academic 
capacity (WS 1). Similarly, identifying Continuing Professional 
Development (CPD) models from around the world can help 
countries establish their own CPD programmes (WS 5). Sharing 
negative experiences was identified as being just as important as 
sharing best practice to raise awareness on common barriers 
(WS 6).  
 
Participants called on FIP to work with member organisations to 
identify all national or regional organizations dedicated 
specifically to academic pharmacy, quality assurance and CPD 
providers; local work can be seeded and aggregated and adapted 
globally; fostering partnerships with global health agencies like 
the World Health Organisation (WHO) is seen as a driver to goal 
achievability (WS 2, 3, 4).  
 
Next steps  
The unique format of the workshops, the innovative approach to 
include stakeholders across an array of settings and the parallel 
structure in all the seven workshops, aided in creating reliable 
findings. Several important lessons were learned which are 
helpful in considering replication of this activity in 5 to 10 years. 
First, it is critical to have a shared framework, a structured 
workshop guide and clear roles and responsibilities at the outset. 
Next having diversity in the country perspectives ensured that 
issues were considered through different geographical and 
cultural lenses. Finally, a team approach including both 
individuals who focus on strategy and individuals who focus on 
implementation led to the success.  
 
By exploring and discussing the main barriers to workforce 
transformation, the multi-national workshop sessions were 
intended as a facilitative tool – due to the innovative way they 
have been developed and conducted – to identify best practices 
for promoting change. The workshop delegates and participants 
represented a range of countries and territories, organizations 
and scopes of expertise. Participant feedback and workshop 
outcomes will be used to feed directly into the global 
transformation agenda led by FIP, under the aegis of FIP 
Education (FIPEd).  
 
The workshop outcomes are critical for future successful 
progress towards the Nanjing outcomes, especially the PWDGs. 
Common themes were identified across the achievability of the 
goals, assessment and metrics, financial incentives and the role 
of FIP in promoting uptake and implementation. The 
achievability of the PWDGs depends on several factors, including 
consideration of local needs and capacities when adopting the 
goals. Engagement with stakeholders and engagement from and 
between professional associations are additional important 
factors to achieving workforce development goals. 
 
The calls for action have been widely shared along with the other 
milestone documents of the workforce roadmap. Examples are 
beginning to emerge regarding the use of the PWDG - 
international conferences have started to request their 
participants to map the work submitted to the PWDGs (for 
example the Life Long Learning in Pharmacy conference) and 
local stakeholders have created collaborations based on the 
PWDGs. Further work still needs to be conducted to prioritize all 
the calls for action and plan to transform education, as it has 
highlighted “now it’s time for action” (Table 1).   
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Figure 1: Summary of the Pharmaceutical Workforce Development Goals (PWDGs) workshop process and structure 
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Table 1: Summary of workshop outcomes and calls for action 
 
Workshop 
title 
Related 
PWDG(s) 
Questions 
addressed Summary of key outcomes Calls for action 
Workshop 1: 
Initial and 
early 
education 
 
 
How to align 
initial education 
with country 
needs? It focused 
on the first 1,000 
days of practice, 
addressing 
suitable training 
and mentorship 
for young 
pharmacist and 
pharmacy 
students. 
The definition scope of PWDG 1 Academic Capacity is 
wide and can include a number of concepts such as: 
having the right mix of academic expertise; quantity, 
quality, infrastructure; optimised learning environment; 
and producing pharmacists who can meet country needs 
and adapt to future ones. A number of drivers for 
implementing the first PWDG were identified, and these 
include: automation (e.g., e-learning and simulation); 
applying best practices; and creating collaborative 
education and training environments. In addition, targets 
for implementation can be found in: developing 
graduate employability skills; reviewing evaluation 
methods; and adopting an outcomes-based learning 
system. 
− While previous work regarding 
counting and describing 
pharmacy-related academics 
has been initiated (e.g. FIP 
Global Pharmacy Workforce 
reports), the outputs of this 
work have not been completed 
nor have they been used 
widely to drive policy.  
− Diagnostic models and 
benchmarking tools are needed 
to enable these numbers and 
competencies to motivate 
global action as well as to be 
useful in needs-based 
educational models.  
− PWDG1 provides an 
opportunity to develop the 
passive and active surveillance 
systems required to produce 
the pharmacy-related 
workforce necessary for safe 
and effective medicines 
discovery, manufacture, 
distribution, and use worldwide.   
Workshop 2: 
Quality 
assurance 
and 
accreditation 
 
How to design, 
implement and 
assess the quality 
of contemporary 
educational 
programmes? 
The challenges in achieving PWDG 3 can lie in: diversity 
within and between countries; resources (e.g., human 
resources and funding); stakeholder engagement; 
resistance to change; and governmental control and 
regulatory constraints. Identifying solutions and 
addressing these challenges can be accomplished 
through: communicating and collaborating with 
stakeholders; developing strategies to incentivise 
stakeholders and government bodies; encouraging more 
association-driven strategies; seeking FIP assistance and 
support; and using tools already developed. Identifying 
gaps, conducting needs analyses, setting implementation 
targets, and capitalising on existing capacities and 
resources can all facilitate achievement of the goal. 
− There is a need to focus on 
demonstrated achievement of 
competencies (for pharmacists 
and pharmaceutical scientists); 
use a systems approach; get 
high level WHO support and FIP 
engagement; engage people 
with the right experience and 
expertise to get the job done; 
and build on existing strengths.  
− One participant noted that we 
have had many reports but 
“now it's time for action." 
Workshop 3: 
Educating 
for 
collaborative 
working 
 
How can 
interprofessional, 
intraprofessional 
education, and 
models of 
collaboration 
between higher 
education 
institutions, 
sectors, science 
and practice be 
achieved? 
Achieving leadership, PWDG 6, depends on students 
being provided with early leadership development 
opportunities and having leadership as part of 
accreditation standards. Applying leadership skills is 
imperative in developing relationships with other 
professionals to enhance collaboration. Achieving PWDG 
8 depends on nurturing collaborative skills in pharmacy 
students from the first semester onward, as well as 
developing more collaborative experiential training 
programmes. Transparency, trust and confidence are 
integral to successful collaborative practice. 
Collaborative practice drivers such as engagement from 
professional associations, credentialing incentives and 
remuneration models can facilitate achieving PWDG 8. 
Examples of ways to disseminating implementation 
include establishing guidelines, scientific publications 
and centres of excellence. 
 
− Developing interprofessional 
education throughout the world 
is a very important initiative for 
preparing pharmacists for team 
models of care.  
− Academia, professional 
associations and regulators all 
play a role in advancing IPE and 
must work together to advance 
this effort. 
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Workshop 4: 
Practice and 
science 
 
How does 
education 
prepare sciences 
to translate into 
practice and 
practice to 
inform science? 
 
Participants discussed goals terminology, demonstrating 
the importance of reaching consensus on definitions. 
They also shared ways of integrating science and practice 
through education. One example was through 
redesigning initial education such that pharmacy 
students are introduced to practice from day 1. In 
addition to undergraduate education, targeting 
postgraduate studies can be a means to science/practice 
integration (e.g., clinical practice-based research and 
data collection). Recalibrating the curriculum to 
accommodate new emerging therapies and advanced 
services was also identified. Introducing innovative 
modules that allow students to design new 
pharmaceutical services would encourage them to think 
about the link between science and practice. 
 
− In summary, participants were 
confused by the workshop title 
and thought that FIP needed to 
improve the clarity of PWDG 7’s 
description (e.g. ‘foundation’ 
was thought to be linked to 
initial education rather than 
workforce education and 
training).  
− Some participants thought it 
would be particularly useful for 
FIP to undertake an 
international survey of CPD 
requirements, resources and 
quality. 
 
Workshop 5: 
Educating 
for future 
goals 
 
How can we 
strategize future 
roles for 
pharmacists and 
pharmaceutical 
scientists, 
including the 
scope, 
technological, 
clinical and 
scientific 
aspects?  
It is important to understand the motivating factors that 
influence pharmacists’ CPD habits in order to address the 
challenges facing goal achievability. It is also important 
for FIP to communicate strategies to member 
organisations to help them engage with stakeholders, 
such as the government, in order to facilitate meeting 
the PWDGs. Updated documents and guidance 
documents are a critical first step towards achieving the 
goals. 
 
Outcomes regarding PWDG 6 on leadership development 
resonate with other workshop outcomes for the same 
goal. Empowering students with leadership-fostering 
activities has been identified as a key driver. Targeting 
mentoring programmes and creating centres of 
excellence can benefit both PWDGs 6 and 9. 
Disseminating the implementation of PWDG 6 depends 
on developing specific processes describing how 
pharmacists can be engaged to take up leadership 
programmes. 
 
− In order to achieve significant 
strides in these CPD and 
leadership goals, we must step 
out of our comfort zones and 
include appropriate social and 
psychological skills in the 
professional learning paradigm 
for our students in our 
universities.  
− Student organizations will need 
financial support to encourage 
budding student leaders in the 
profession.  
− Mentors should encourage 
talented pharmacists to seek 
leadership positions of 
influence in our communities.  
− The organization will need to 
define core skills, behaviours 
and attitudes consistent with 
strong leadership at the 
student, administrator and 
professional practice level. 
− FIP should play a more active 
role in supporting national 
development of CPD 
Programmes and efforts to 
initiate such particularly in 
developing countries.  
− Leadership development 
programmes should be 
targeted to key lead 
pharmacists in government 
positions that could steer the 
profession nationally and 
worldwide. 
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Workshop 6: 
Educating 
for advanced 
practice 
 
How can 
specialisation, 
professional 
development, 
professional 
recognition and 
credentialing, 
advance 
practice? 
There are major variances among different countries, in 
terms of terminology recognition, legislation and scope 
of practice, infrastructures of practice sites, and existing 
support structure (e.g., professional organisations). 
Sharing experiences (both positive and negative) and 
best practices is important to achieving the goals. There 
is a need for top-down policy and educational structural 
changes to progress advanced and specialist 
development and practice. Expanding the role of FIPEd 
beyond congresses and reports to disseminating ”how 
to” guides that can assist with real policy 
implementation is important. Also, developing a global 
advanced practice and specialisation framework (in 
addition to the FIP competency framework that already 
exists) can help countries advance practice in their 
jurisdictions. 
− Pharmacy needs a workforce 
that is flexible, capable, 
demonstrable, adaptable, able 
to move across sectors and 
adapt to changing care models. 
To achieve this, pharmacists 
should not specialise too early 
in their training.  
− Foundation training should 
underpin advancement, and 
advanced and specialist 
development should follow, 
whenever relevant for both 
practitioner and patient. 
 
Workshop 7: 
Clinical 
practice 
 
How to transform 
education of 
pharmacists to 
better prepare 
them for clinical 
roles? 
There is consensus that clinical practice refers to patient-
focused care in any practice setting and that expanding 
the role of pharmacists in clinical practice is both 
desirable and achievable. There are a number of drivers 
to embracing clinical roles: refining practice scope and 
activities to have time for clinical practice; fostering new 
ways of working that connect pharmacists to other 
members of the healthcare team; establishing 
remuneration systems for the outcomes of clinical 
services; and assuring competence to deliver excellent 
patient care. Additionally, there are regional differences 
regarding progress toward clinical services, and countries 
developing new services may benefit from learning 
lessons from others that have already implemented 
clinical practices. 
− The workshop consensus was 
that the role of the pharmacist 
should be clinical practice: it is 
desirable, achievable, and 
applicable in any setting.  
− The presentations suggested 
that there are positive examples 
from countries in both high and 
low resource settings.  
Pharmacy leaders are needed 
to facilitate the changes 
required to advance clinical 
practice.  
− Standards for educating and 
training clinical pharmacists 
need to be agreed upon and 
disseminated.  
− Regions developing new clinical 
services may benefit from 
learning successes and avoiding 
hurdles of others who have 
implemented clinical practices.  
− It is imperative for professional 
organizations to provide forums 
to facilitate this learning.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
